Jereme M. Sylvain

EVP, Chief Financial OfficeratDexcom· In proxies 2021–2025

Pay in FY2025+21% from the year before · Dexcom stock -14.7% the same year

Jereme M. Sylvain was paid $7.1M in FY2025 (Dec), up 21%. Dexcom stock fell 14.7% that year.

Pay$100 in the stock at the end of FY20 → $72

Pay is from the Summary Compensation Table of each Dexcom proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

DexcomPublic company · 5 yr
- EVP, Chief Financial Officer2021 – Present · 5 yrStock in role -11%

Roles come from the proxy statements of each company.

Activity

Pay
Dexcom CFO pay rose 21% to $7.1M. The stock fell 15% in FY2025 (Dec).
DEF 14AApr 15, 2026
Pay
Dexcom CFO pay rose 38% to $5.9M. The stock fell 37% in FY2024 (Dec).
DEF 14AMar 27, 2025
Pay
Dexcom CFO pay rose 20% to $4.3M. The stock rose 10% in FY2023 (Dec).
DEF 14AApr 22, 2024
Pay
Dexcom CFO pay fell 25% to $3.5M. The stock fell 16% in FY2022 (Dec).
DEF 14AApr 22, 2024

For the press:Download CSV Download PNG How to use our data

Two people shown as one, or a wrong number?